The Current Status of Solitary Fibrous Tumor

International Journal of Surgical Pathology

Volumn 24, Issue 4, 2016, Pages 281-292

  Thway, Khin ^a   Ng, Wen ^a   Noujaim, Jonathan ^a   Jones, Robin L ^a   Fisher, Cyril ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

dedifferentiation; fat forming soft tissue tumor; gene rearrangement; genetics; giant cell angiofibroma; hemangiopericytoma; lipomatous hemangiopericytoma; malignant; NAB2 STAT6; pathology; sarcoma; solitary fibrous tumor; STAT6; translocation

Indexed keywords

NAB2 PROTEIN; PROTEIN; STAT6 PROTEIN; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; SOLITARY FIBROUS TUMOR; TUMOR DIAGNOSIS;

HUMANS; SOLITARY FIBROUS TUMORS;

EID: 84966650425     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896915627485     Document Type: Review

References (102)

1. Stout AP, Murray MR,. Hemangiopericytoma: a vascular tumor featuring Zimmermann's pericytes. Ann Surg. 1942; 116: 26-33.
2. Fisher C,. Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas. Ultrastruct Pathol. 2004; 28: 291-305.
3. Tihan T, Viglione M, Rosenblum MK, Olivi A, Burger PC,. Solitary fibrous tumors in the central nervous system. A clinicopathologic review of 18 cases and comparison to meningeal hemangiopericytomas. Arch Pathol Lab Med. 2003; 127: 432-439.
4. Thompson LD, Miettinen M, Wenig BM,. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol. 2003; 27: 737-749.
5. Chan JK,. Solitary fibrous tumour-everywhere, and a diagnosis in vogue. Histopathology. 1997; 31: 568-576.
6. Schweizer L, Koelsche C, Sahm F, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013; 125: 651-658.
7. Dervan PA, Tobin B, O'Connor M,. Solitary (localized) fibrous mesothelioma: evidence against mesothelial cell origin. Histopathology. 1986; 10: 867-875.
8. Steinetz C, Clarke R, Jacobs GH, Abdul-Karim FW, Petrelli M, Tomashefski JF Jr., Localized fibrous tumors of the pleura: correlation of histopathological, immunohistochemical and ultrastructural features. Pathol Res Pract. 1990; 186: 344-357.
9. Said JW, Nash G, Banks-Schlegel S, Sassoon AF, Shintaku IP,. Localized fibrous mesothelioma: an immunohistochemical and electron microscopic study. Hum Pathol. 1984; 15: 440-443.
10. el-Naggar AK, Ro JY, Ayala AG, Ward R, Ordonez NG,. Localized fibrous tumor of the serosal cavities. Immunohistochemical, electron-microscopic, and flow-cytometric DNA study. Am J Clin Pathol. 1989; 92: 561-565.
11. Burrig KF, Kastendieck H,. Ultrastructural observations on the histogenesis of localized fibrous tumours of the pleura (benign mesothelioma). Virchows Arch A Pathol Anat Histopathol. 1984; 403: 413-424.
12. Nielsen GP, O'Connell JX, Dickersin GR, Rosenberg AE,. Solitary fibrous tumor of soft tissue: a report of 15 cases, including 5 malignant examples with light microscopic, immunohistochemical, and ultrastructural data. Mod Pathol. 1997; 10: 1028-1037.
13. Fukunaga M, Naganuma H, Nikaido T, Harada T, Ushigome S,. Extrapleural solitary fibrous tumor: a report of seven cases. Mod Pathol. 1997; 10: 443-450.
14. Hasegawa T, Matsuno Y, Shimoda T, Hasegawa F, Sano T, Hirohashi S,. Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior. Hum Pathol. 1999; 30: 1464-1473.
15. Thway K, Jordan S, Fisher C, Nicholson AG,. Updates in the approach to intrathoracic sarcomas [published online July 1, 2015]. Histopathology. doi: 10.1111/his.12771.
16. Daigeler A, Lehnhardt M, Langer S, et al. Clinicopathological findings in a case series of extrathoracic solitary fibrous tumors of soft tissues. BMC Surg. 2006; 6: 10.
17. Fletcher CD, Bridge JA, Lee JC,. Extrapleural solitary fibrous tumour. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon, France: IARC; 2013: 80-82.
18. Demicco EG, Park MS, Araujo DM, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012; 25: 1298-1306.
19. Bauer JL, Miklos AZ, Thompson LD,. Parotid gland solitary fibrous tumor: a case report and clinicopathologic review of 22 cases from the literature. Head Neck Pathol. 2012; 6: 21-31.
20. Sigel JE, Goldblum JR,. Solitary fibrous tumor of the skin. Am J Dermatopathol. 2001; 23: 275-278.
21. Fukasawa Y, Takada A, Tateno M, et al. Solitary fibrous tumor of the pleura causing recurrent hypoglycemia by secretion of insulin-like growth factor II. Pathol Int. 1998; 48: 47-52.
22. Strom EH, Skjorten F, Aarseth LB, Haug E,. Solitary fibrous tumor of the pleura. An immunohistochemical, electron microscopic and tissue culture study of a tumor producing insulin-like growth factor I in a patient with hypoglycemia. Pathol Res Pract. 1991; 187: 109-113.
23. Steigen SE, Schaeffer DF, West RB, Nielsen TO,. Expression of insulin-like growth factor 2 in mesenchymal neoplasms. Mod Pathol. 2009; 22: 914-921.
24. Wignall OJ, Moskovic EC, Thway K, Thomas JM,. Solitary fibrous tumors of the soft tissues: review of the imaging and clinical features with histopathologic correlation. AJR Am J Roentgenol. 2010; 195: W55-W62.
25. Garcia-Bennett J, Olive CS, Rivas A, Dominguez-Oronoz R, Huguet P,. Soft tissue solitary fibrous tumor. Imaging findings in a series of nine cases. Skeletal Radiol. 2012; 41: 1427-1433.
26. Gold JS, Antonescu CR, Hajdu C, et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer. 2002; 94: 1057-1068.
27. Cranshaw IM, Gikas PD, Fisher C, Thway K, Thomas JM, Hayes AJ,. Clinical outcomes of extra-thoracic solitary fibrous tumours. Eur J Surg Oncol. 2009; 35: 994-998.
28. Rao N, Colby TV, Falconieri G, Cohen H, Moran CA, Suster S,. Intrapulmonary solitary fibrous tumors: clinicopathologic and immunohistochemical study of 24 cases. Am J Surg Pathol. 2013; 37: 155-166.
29. Mosquera JM, Fletcher CD,. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component-is this dedifferentiated SFT? Am J Surg Pathol. 2009; 33: 1314-1321.
30. Collini P, Negri T, Barisella M, et al. High-grade sarcomatous overgrowth in solitary fibrous tumors: a clinicopathologic study of 10 cases. Am J Surg Pathol. 2012; 36: 1202-1215.
31. Cardillo G, Carbone L, Carleo F, et al. Solitary fibrous tumors of the pleura: an analysis of 110 patients treated in a single institution. Ann Thorac Surg. 2009; 88: 1632-1637.
32. DeVito N, Henderson E, Han G, et al. Clinical characteristics and outcomes for solitary fibrous tumor (SFT): a single center experience. PLoS One. 2015; 10: e0140362.
33. Bishop AJ, Zagars GK, Demicco EG, Wang WL, Feig BW, Guadagnolo BA,. Soft tissue solitary fibrous tumor: combined surgery and radiation therapy results in excellent local control [published online August 11, 2015]. Am J Clin Oncol. doi: 10.1097/COC.0000000000000218
34. Bylicki O, Rouvière D, Cassier P, et al. Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice setting. J Thorac Oncol. 2015; 10: 309-315.
35. van Houdt W, Westerveld CMA, Vrijenhoek JEP, et al. Prognosis of solitary fibrous tumors: a multicenter study. Ann Surg Oncol. 2013; 20: 4090-4095.
36. Lococo F, Cesario A, Cardillo G, et al. Malignant solitary fibrous tumors of the pleura: retrospective review of a multicenter series. J Thorac Oncol. 2012; 7: 1698-1706.
37. Vallat Decouvelaere AV, Dry SM, Fletcher CD,. Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol. 1998; 22: 1501-1511.
38. Constantinidou A, Jones RL, Olmos D, et al. Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour. Acta Oncol. 2012; 51: 550-554.
39. Stacchiotti S, Tortoreto M, Bozzi F, et al. Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics. Clin Cancer Res. 2013; 19: 5192-5201.
40. Khalifa J, Ouali M, Chaltiel L, et al. Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group. BMC Cancer. 2015; 15: 700.
41. Maruzzo M, Martin-Liberal J, Messiou C, et al. Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience. Clin Sarcoma Res. 2015; 5: 5.
42. Noujaim J, Thway K, Sheri A, Keller C, Jones RL,. Histology-driven therapy: the importance of diagnostic accuracy in guiding systemic therapy of soft tissue tumors [published online September 22, 2015]. Int J Surg Pathol. doi: 10.1177/1066896915606971
43. Stacchiotti S, Negri T, Libertini M, et al. Sunitinib malate in solitary fibrous tumor (SFT). Ann Oncol. 2012; 23: 3171-3179.
44. Valentin T, Fournier C, Penel N, et al. Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO). Invest New Drugs. 2013; 31: 1626-1627.
45. Park MS, Patel SR, Ludwig JA, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011; 117: 4939-4947.
46. Park M, Ravi V, Araujo D,. Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor. Curr Opin Oncol. 2010; 22: 351-355.
47. Chmielecki J, Crago AM, Rosenberg M, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013; 45: 131-132.
48. Robinson DR, Wu YM, Kalyana-Sundaram S, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013; 45: 180-185.
49. Mohajeri A, Tayebwa J, Collin A, et al. Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer. 2013; 52: 873-886.
50. Tai HC, Chuang IC, Chen TC, et al. NAB2-STAT6 fusion types account for clinicopathological variations in solitary fibrous tumors. Mod Pathol. 2015; 28: 1324-1335.
51. Barthelmess S, Geddert H, Boltze C, et al. Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol. 2014; 184: 1209-1218.
52. Hajdu M, Singer S, Maki RG, Schwartz GK, Keohan ML, Antonescu CR,. IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting. J Pathol. 2010; 221: 300-307.
53. Bertucci F, Bouvier-Labit C, Finetti P, et al. Gene expression profiling of solitary fibrous tumors. PLoS One. 2013; 8: e64497.
54. Demicco EG, Wani K, Fox PS, et al. Histologic variability in solitary fibrous tumors reflects angiogenic and growth factor signaling pathway alterations. Hum Pathol. 2015; 46: 1015-1026.
55. de Saint Aubain Somerhausen N, Rubin BP, Fletcher CD,. Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis. Mod Pathol. 1999; 12: 463-471.
56. Guillou L, Gebhard S, Coindre JM,. Orbital and extraorbital giant cell angiofibroma: a giant cell-rich variant of solitary fibrous tumor? Clinicopathologic and immunohistochemical analysis of a series in favor of a unifying concept. Am J Surg Pathol. 2000; 24: 971-979.
57. Guillou L, Gebhard S, Coindre JM,. Lipomatous hemangiopericytoma: a fat-containing variant of solitary fibrous tumor? Clinicopathologic, immunohistochemical, and ultrastructural analysis of a series in favor of a unifying concept. Hum Pathol. 2000; 31: 1108-1115.
58. Sigel JE, Fisher C, Vogt D, Goldblum JR,. Giant cell angiofibroma of the inguinal region. Ann Diagn Pathol. 2000; 4: 240-244.
59. Dei Tos AP, Seregard S, Calonje E, Chan JK, Fletcher CD,. Giant cell angiofibroma. A distinctive orbital tumor in adults. Am J Surg Pathol. 1995; 19: 1286-1293.
60. England DM, Hochholzer L, McCarthy MJ,. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol. 1989; 13: 640-658.
61. Lee JC, Fletcher CD,. Malignant fat-forming solitary fibrous tumor (so-called “lipomatous hemangiopericytoma†): clinicopathologic analysis of 14 cases. Am J Surg Pathol. 2011; 35: 1177-1185.
62. Zhang PJ, Brooks JJ,. Malignant solitary fibrous tumors: a transformation and dedifferentiation phenomenon in some cases [abstract]. Mod Pathol. 2004; 17: 21A.
63. Bini A, Grazia M, Stella F, Petrella F, Bazzocchi R,. Giant malignant fibrous histiocytoma of the pleura arising from solitary fibrous tumour. Thorax. 2004; 59: 544.
64. Thway K, Hayes A, Ieremia E, Fisher C,. Heterologous osteosarcomatous and rhabdomyosarcomatous elements in dedifferentiated solitary fibrous tumor: further support for the concept of dedifferentiation in solitary fibrous tumor. Ann Diagn Pathol. 2013; 17: 457-463.
65. Natkunam Y, Rouse RV, Zhu S, Fisher C, van De Rijn M,. Immunoblot analysis of CD34 expression in histologically diverse neoplasms. Am J Pathol. 2000; 156: 21-27.
66. Flint A, Weiss SW,. CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma. Hum Pathol. 1995; 26: 428-431.
67. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S, Hirose T, Sano T,. Frequent expression of bcl-2 protein in solitary fibrous tumors. Jpn J Clin Oncol. 1998; 28: 86-91.
68. Ng TL, Gown AM, Barry TS, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol. 2005; 18: 68-74.
69. Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL,. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol. 2014; 27: 390-395.
70. Yoshida A, Tsuta K, Ohno M, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol. 2014; 38: 552-559.
71. Cheah AL, Billings SD, Goldblum JR, Carver P, Tanas MZ, Rubin BP,. STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics. Pathology. 2014; 46: 389-395.
72. Doyle LA, Tao D, Marino-Enriquez A,. STAT6 is amplified in a subset of dedifferentiated liposarcoma. Mod Pathol. 2014; 27: 1231-1237.
73. Demicco EG, Harms PW, Patel RM, et al. Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol. 2015; 143: 672-682.
74. Vivero M, Doyle LA, Fletcher CD, Mertens F, Hornick JL,. GRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling. Histopathology. 2014; 65: 71-80.
75. Hanau CA, Miettinen M,. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol. 1995; 26: 440-449.
76. Lecoutere E, Creytens D,. Multifocal cytokeratin expression in pleural and abdominal malignant solitary fibrous tumors: an unusual diagnostic pitfall. Virchows Arch. 2015; 467: 119-121.
77. Chen BJ, Marino-Enriquez A, Fletcher CD, Hornick JL,. Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications. Am J Surg Pathol. 2012; 36: 1119-1128.
78. Fritchie KJ, Carver P, Sun Y, et al. Solitary fibrous tumor: is there a molecular relationship with cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma? Am J Clin Pathol. 2012; 137: 963-970.
79. Sheng WQ, Hashimoto H, Okamoto S, et al. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans. J Pathol. 2001; 194: 88-94.
80. O'Brien KP, Seroussi E, Dal Cin P, et al. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer. 1998; 23: 187-193.
81. Navarro M, Simon MP, Migeon C, Turc-Carel C, Pedeutour F,. COL1A1-PDGFB fusion in a ring chromosome 4 found in a dermatofibrosarcoma protuberans. Genes Chromosomes Cancer. 1998; 23: 263-266.
82. Hornick JL, Fletcher CD,. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol. 2002; 117: 188-193.
83. Novelli M, Rossi S, Rodriguez-Justo M, et al. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology. 2010; 57: 259-270.
84. Dei Tos AP, Doglioni C, Piccinin S, et al. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol. 2000; 190: 531-536.
85. Nakayama T, Toguchida J, Wadayama B, Kanoe H, Kotoura Y, Sasaki MS,. MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors. Int J Cancer. 1995; 64: 342-346.
86. Nilbert M, Rydholm A, Mitelman F, Meltzer PS, Mandahl N,. Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet. 1995; 83: 32-36.
87. Pedeutour F, Forus A, Coindre JM, et al. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer. 1999; 24: 30-41.
88. Pilotti S, Della Torre G, Lavarino C, et al. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. J Pathol. 1998; 185: 188-190.
89. Coindre JM, Hostein I, Maire G, et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol. 2004; 203: 822-830.
90. Binh MB, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005; 29: 1340-1347.
91. Thway K, Flora R, Shah C, Olmos D, Fisher C,. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am J Surg Pathol. 2012; 36: 462-469.
92. Foo WC, Cruise MW, Wick MR, Hornick JL,. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol. 2011; 135: 839-844.
93. Thway K, Fisher C,. Synovial sarcoma: defining features and diagnostic evolution. Ann Diagn Pathol. 2014; 18: 369-380.
94. Fisher C,. Synovial sarcoma. Ann Diagn Pathol. 1998; 2: 401-421.
95. Terry J, Saito T, Subramanian S, et al. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol. 2007; 31: 240-246.
96. Knight J, Reeves B, Smith S, et al. Cytogenetic and molecular analysis of synovial sarcoma. Int J Oncol. 1992; 1: 747-752.
97. Smith S, Reeves BR, Wong L, Fisher C,. A consistent chromosome translocation in synovial sarcoma. Cancer Genet Cytogenet. 1987; 26: 179-180.
98. Thway K, Fisher C,. Malignant peripheral nerve sheath tumor: pathology and genetics. Ann Diagn Pathol. 2014; 18: 109-116.
99. Sheng WQ, Hisaoka M, Okamoto S, et al. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues. Am J Clin Pathol. 2001; 115: 348-355.
100. Fetsch JF, Weiss SW,. Ectopic hamartomatous thymoma: clinicopathologic, immunohistochemical, and histogenetic considerations in four new cases. Hum Pathol. 1990; 21: 662-668.
101. Fetsch JF, Laskin WB, Michal M, et al. Ectopic hamartomatous thymoma: a clinicopathologic and immunohistochemical analysis of 21 cases with data supporting reclassification as a branchial anlage mixed tumor. Am J Surg Pathol. 2004; 28: 1360-1370.
102. Macagno N, Figarella-Branger D, Mokthari K, et al. Differential diagnosis of meningeal SFT-HPC and meningioma: which immunohistochemical markers should be used [published online October 6, 2015]? Am J Surg Pathol. doi: 10.1097/PAS.0000000000000526